Clinical activity of olaparib in urothelial bladder cancer with dna damage response gene mutations

Randy F. Sweis; Brian Heiss; Jeremy Segal; Lauren Ritterhouse; Sabah Kadri; Jane E. Churpek; Kenisha Allen; Dawn Conway; Carolyn Marinier; Norm D. Smith; Sean P. Pitroda; Walter M. Stadler

doi:10.1200/PO.18.00264

Clinical activity of olaparib in urothelial bladder cancer with dna damage response gene mutations

Randy F. Sweis^*, Brian Heiss, Jeremy Segal, Lauren Ritterhouse, Sabah Kadri, Jane E. Churpek, Kenisha Allen, Dawn Conway, Carolyn Marinier, Norm D. Smith, Sean P. Pitroda, Walter M. Stadler

^*Corresponding author for this work

Preventive Medicine

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	1-7
Number of pages	7
Journal	JCO Precision Oncology
Issue number	2
DOIs	https://doi.org/10.1200/PO.18.00264
State	Published - 2018

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/PO.18.00264

Cite this

@article{211f741c93544d4d901a4a1c2349fc53,

title = "Clinical activity of olaparib in urothelial bladder cancer with dna damage response gene mutations",

author = "Sweis, {Randy F.} and Brian Heiss and Jeremy Segal and Lauren Ritterhouse and Sabah Kadri and Churpek, {Jane E.} and Kenisha Allen and Dawn Conway and Carolyn Marinier and Smith, {Norm D.} and Pitroda, {Sean P.} and Stadler, {Walter M.}",

year = "2018",

doi = "10.1200/PO.18.00264",

language = "English (US)",

pages = "1--7",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

number = "2",

}

TY - JOUR

T1 - Clinical activity of olaparib in urothelial bladder cancer with dna damage response gene mutations

AU - Sweis, Randy F.

AU - Heiss, Brian

AU - Segal, Jeremy

AU - Ritterhouse, Lauren

AU - Kadri, Sabah

AU - Churpek, Jane E.

AU - Allen, Kenisha

AU - Conway, Dawn

AU - Marinier, Carolyn

AU - Smith, Norm D.

AU - Pitroda, Sean P.

AU - Stadler, Walter M.

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85083938291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85083938291&partnerID=8YFLogxK

U2 - 10.1200/PO.18.00264

DO - 10.1200/PO.18.00264

M3 - Article

C2 - 35135165

AN - SCOPUS:85083938291

SN - 2473-4284

SP - 1

EP - 7

JO - JCO Precision Oncology

JF - JCO Precision Oncology

IS - 2

ER -

Clinical activity of olaparib in urothelial bladder cancer with dna damage response gene mutations

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this